Furthermore, specific DNA methylation biomarkers, including epigenetic modifications in APC, RASSFI, and FOXA1, are emerging as promising candidates for a gene panel that could facilitate the early detection of breast cancer via non-invasive liquid biopsy methodologies (66). This evidence concerns the gene FOXA1 and breast cancer.